New MS drug could slow symptoms of 'untreatable' form of disease

Siponimod offers hope for people with secondary progressive MS, in which disabilities get worse over time

A new drug for multiple sclerosis could slow the progression of symptoms of a form of the disease for which effective treatments have proved elusive, research suggests.

It is thought about 100,000 people in the UK and 2,500,000 people worldwide have MS, a neurological condition that can affect speech, movement of limbs and vision, among other things.